An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment with methotrexate.

Trial Profile

An open label study to evaluate the safety and efficacy of rituximab in patients with active rheumatoid arthritis who have had an inadequate response to prior treatment with methotrexate.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2014

At a glance

  • Drugs Rituximab (Primary) ; Methotrexate
  • Indications Rheumatoid arthritis
  • Focus Adverse reactions
  • Sponsors Roche
  • Most Recent Events

    • 05 Dec 2011 Actual initiation date changed from Mar 2008 to Oct 2007 as reported by ClinicalTrials.gov.
    • 05 Dec 2011 Actual patient number is 20 according to ClinicalTrials.gov.
    • 18 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top